Biotech

All Articles

ReNeuron leaving behind AIM swap after missing out on fundraising objective

.ReNeuron has joined the lengthy checklist of biotechs to leave Greater london's AIM securities mark...

MBX declare IPO to take challenger to Ascendis into period 3

.MBX Biosciences has included in the latest outbreak of IPO filings. The biotech, which filed its ow...

FDA broadens probing in to Lykos' MDMA tests: WSJ

.For Lykos Therapeutics and also the provider's would-be MDMA-assisted treatment for trauma (PTSD), ...

Gene editor Volume giving up 131 laborers

.Only days after gene editor Tome Biosciences declared unrevealed operational slices, a more clear i...

Repare gives up 25% of staff as biotech halts preclinical R&ampD

.Repare Therapy is actually laying off an one-fourth of its workforce as the oncology biotech lessen...

J &amp J declare FDA authorization of $6.5 B autoimmune drug

.Johnson &amp Johnson has taken an additional step toward recognizing a gain on its $6.5 billion nip...

Gain's period 1 gain paves way to prove Parkinson's medicine's worth

.Gain Rehabs has actually specified its own direct verifying the performance of its own Parkinson's ...

Actinogen documents new stage 2 data to recover depression drug

.Actinogen Medical's hopes-- and also stock cost-- have rebounded slightly coming from earlier this ...

Pfizer as well as Crown jewel include Quotient to multibillion-dollar equation

.Flagship Pioneering as well as Pfizer have incorporated Quotient right into their 10-program allian...

Bayer markers $547M deal to press limits of noncoding RNA

.Bayer execs were eager to tension to Strong this summer season that the German pharma titan's cravi...